Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance

Stock Track

02-27

Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.

The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.

Highlights from Ardent Health's Q4 2024 results:

Total revenue grew 19.3% year-over-year to $1.61 billion
Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share
Adjusted EBITDA increased 213% year-over-year to $183 million

In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.

Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1161392122"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161392122\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1161392122?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161392122","market":"hk","top_or_hot":-1,"title":"Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance","media":"Stock Track","content":"<p>Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.</p>\n\n<p>The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.</p>\n\n<p>Highlights from Ardent Health's Q4 2024 results:\n<ul>\n<li>Total revenue grew 19.3% year-over-year to $1.61 billion</li>\n<li>Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share</li>\n<li>Adjusted EBITDA increased 213% year-over-year to $183 million</li>\n</ul>\n</p>\n\n<p>In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.</p>\n\n<p>Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 06:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.</p>\n\n<p>The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.</p>\n\n<p>Highlights from Ardent Health's Q4 2024 results:\n<ul>\n<li>Total revenue grew 19.3% year-over-year to $1.61 billion</li>\n<li>Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share</li>\n<li>Adjusted EBITDA increased 213% year-over-year to $183 million</li>\n</ul>\n</p>\n\n<p>In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.</p>\n\n<p>Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1161392122","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161392122","pubTimestamp":1740607376,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ardent Health Partners  stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.Total revenue grew 19.3% year-over-year to $1.61 billion. Net income at","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"股票赛道Ardent Health Partners盘后飙升5.28%，得益于强劲的第四季度业绩和乐观的指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDT":1},"content_text":"Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.\nThe healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.\nHighlights from Ardent Health's Q4 2024 results:\n\nTotal revenue grew 19.3% year-over-year to $1.61 billion\nNet income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share\nAdjusted EBITDA increased 213% year-over-year to $183 million\n\nIn addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.\nArdent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}